|
市場調查報告書
用於生物製劑的細胞化驗分析趨勢:2011年
Cell-Based Assays For Biologics Trends 2011
| 出版商 |
HTStec Ltd |
| 出版日期 |
2011年08月 |
商品編碼 |
217776 |
| 內容資訊 |
英文 54 Pages |
| 價格 |
|
|
用於生物製劑的細胞化驗分析趨勢:2011年 是由出版商HTStec Ltd在2011年08月所出版的。
這份英文市場調查報告書包含54 Pages 價格從美金2500起跳。
本報告提供開發藥劑下用於生物製劑的生化分析現狀和最終消費者的見解，未來的必要條件等彙整資料，為您概述為以下內容。
- 摘要整理
- 目錄
- 調查方法
- 受訪者所屬研究機構
- 受訪者的出身地區
- 受訪者所屬企業或組織
- 受訪者的事業領域
- 受訪者的工作職位
- 受訪者的主要小組活動
- 用於生物製劑的細胞化驗分析開發/對使用的興趣程度
- 用於生物製劑的藥物發明比率
- 研究生物製劑/目標疾病領域
- 今後3∼5年最重要的生物製劑目標
- 結合生物學篩檢的細胞化驗分析目前使用情形
- 結合生物學篩檢的細胞化驗分析未來使用情形
- 生物學篩檢各種化驗使用趨勢的變化
- 用於生物製劑的細胞化驗分析最重要促進因素
- 用於生物製劑的細胞化驗分析最大限制因素
- 調查結果摘要(1)
- 對用於生物製劑的細胞化驗分析工作流程最關注之事
- 受訪者用於生物製劑的細胞化驗分析所使用的生物學指標種類
- 用於生物製劑的細胞化驗分析最被要求的化驗格式
- 用於生物製劑的細胞化驗分析最常用的檢測技術
- 評估生物製劑目前所施行的生物檢定種類
- 為了對應ADC化驗生物學候補檢驗，對生物檢定可能試劑存取的興趣
- 為開發生物製劑化驗，以報告者為主的化驗的使用
- 實證ADCC化驗的作用機制，以報告者為主的化驗的適當性
- 對用於生物製劑的多重化驗的興趣
- 對施行384-Well Plates的生物製劑生物檢定的興趣
- 用於細胞化驗分析的生物製劑批次放行中最有魅力的特徵
- 根據批號的生物檢定套件及零件的購買必要條件
- 關於零件組的得到性最大計劃必要條件
- 生物製劑用生物檢定開發/採購之處
- 對冷凍細胞的生物檢定採購的興趣
- 調查結果摘要(2)
- 用於生物製劑的細胞化驗分析的使用:各單位樣本
- 用於生物製劑的細胞化驗分析的使用:樣品的稀釋
- 用於生物製劑的細胞化驗分析的使用:樣品及稀釋品
- 用於生物製劑的細胞化驗分析的使用:Number Control Wells
- 用於生物製劑的細胞化驗分析的使用:96-Well Plates處理數/月
- 用於生物製劑的細胞化驗分析的最重要效能指標
- 用於生物製劑的細胞化驗分析年度預算
- 2011年用於生物製劑的細胞化驗分析預算詳細內容
- 生物製劑細胞化驗分析市場預測
- 生物製劑細胞化驗分析市場預測詳細內容
- 每個用於生物製劑的細胞化驗分析的價格
- 用於生物製劑的細胞化驗分析的商業的供應商
- 用於生物製劑的細胞化驗分析市場供應商市場佔有率
- 用於生物製劑的細胞化驗分析的未滿足需求
- 調查結果摘要(3)
Abstract
HTStec' s Cell-Based Assays For Biologics Trends 2011 report was published on 3
August 2011. This 54 page market report summarizes the results of HTStec' s
industry-wide global web-based benchmarking survey on cell-based assays for
biologics carried out in July 2011. The study was initiated by HTStec as part
of its ongoing tracking of emerging life science marketplaces. The
questionnaire was compiled to meet the needs and interests of the cellular
assay reagent vendor community. The main objectives were to comprehensively
document current end user opinions, practices and preferences in the
development of bioassays for large molecule (biologics) applications in drug
discovery, and to understand future requirements. The report is based on 101
responses from University Research Labs, Pharma and Biotech, mainly in North
America and Europe.
Table of Contents
- Executive Summary
- Table of Contents
- Survey Methodology
- Lab Origin of Survey Respondents
- Respondent' s Geographic Origin
- Respondent' s Company or Organisational Origin
- Respondent' s Job Role
- Respondent' s Main Group Activity
- Level of Interest in Developing/Using Cell-Based Assays for Biologics
- Proportion of Drug Discovery Efforts Directed Towards Biologics
- Disease Areas Investigating/Targeting With Biologic Drugs
- Most Important Targets for Biologic Drugs in Next 3-5 Years
- Current Usage of Binding Versus Cell-Based Assays for Biologic Screening
- Future Usage of Binding Versus Cell-Based Assays for Biologic Screening
- Anticipated Change in Different Assay Type Usage for Biologic Screening
- Most Important Drivers for Cell-Based Assays for Biologics
- Biggest Limitations of Cell-Based Assays for Biologics
- Summary of Survey Findings (1)
- Components of Most Interest to Biologics Cell-Based Assay Workflow
- Types of Biological Matrices Respondents are Using in Cell-Based Assays
- Most Wanted Assay Formats/Readouts for Cell-Based Assays for Biologics
- Detection Technologies Most Used for Cell-Based Assays for Biologics
- Bioassay Types Currently Performed for the Evaluation of Biologics
- Interest in Accessing Bioassay Qualified Reagents to Address Testing of
Biologics Candidates in ADC Assays
- Current Use of Reporter-Based Assays for Biologics Assay Development
- Relevance of a Reporter-Based Assay That Demonstrates Mechanism of Action
in ADCC Assays
- Interest in Multiplexed Assays for Biologics
- Interest in Performing Biologics Bioassays in 384-Well Plates
- Feature that is Most Attractive for Biologics Lot Release, Using
Cell-Based Assays
- Requirement to Purchase Bioassay Kit or Component Under Lot Numbers
- Maximum Timeline Requirements for Component Lot Availability
- Requirement for Bioassays to be Manufactured Under GMP Conditions
- Where Bioassays for Biologics are Developed/Sourced
- Interest in Sourcing Bioassays with Frozen Ready-To-Use Cells
- Summary of Survey Findings (2)
- Use of Cell-Based Assays for Biologics - Unique Samples per Plate
- Use of Cell-Based Assays for Biologics - Dilutions per Unique Sample
- Use of Cell-Based Assays for Biologics - Sample or Dilution Replicates
- Use of Cell-Based Assays for Biologics - Number Control Wells per Plate
- Use of Cell-Based Assays for Biologics - 96-Well Plates Processed/Month
- Most Critical Performance Parameters in Cell-Based Assays for Biologics
- Annual Budget for Biologics Cell-Based Assays
- Breakdown of 2011 Budget for Biologics Cell-Based Assays
- Biologics Cell-Based Assays Market Estimate (1)
- Biologics Cell-Based Assays Market Estimate (2)
- Breakdown of Biologics Cell-Based Assays Market Estimate
- Price Paid per Well for Cell-Based Assays in Biologics (1)
- Price Paid per Well for Cell-Based Assays in Biologics (2)
- Commercial Suppliers of Cell-Based Assays for Biologics (1)
- Commercial Suppliers of Cell-Based Assays for Biologics (2)
- Estimated Supplier Share of Cell-Based Assays for Biologics Market
- Unmet Needs in the Area of Cell-Based Assays for Biologics
- Summary of Survey Findings (3)
|
